However, contradictory effects of Wnt5a have been reported in breast cancer, in which a loss of Wnt5a expression was associated with high-histological grade, high-mitotic index, and negative expression of the estrogen and progesterone receptors in the invasive ductal breast cancer [57]. Here, WNT5A is linked to breast carcinoma.